{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:53:50Z","timestamp":1762458830698},"reference-count":42,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T00:00:00Z","timestamp":1237939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Oral Pathology Medicine"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Mucocutaneous type of Behcet\u2019s disease (MCBD) is a multisystemic inflammatory disease with oral and genital ulcers with or without skin lesions.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A solid phase, two\u2010site sequential chemiluminescent immunometric assay was used to measure serum levels of interleukin (IL)\u20106, IL\u20108 and tumour necrosis factor (TNF)\u2010\u03b1 in 54 normal control subjects and in 64 MCBD patients before and after treatment with levamisole plus colchicine.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> We found that 67%, 83% or 67% of MCBD patients had a serum IL\u20106, IL\u20108 or TNF\u2010\u03b1 level greater than the upper normal limit of 4.7, 8.7 or 7.4\u2003pg\/ml, respectively. The mean serum level of IL\u20106 (9.9\u2003\u00b1 2.4\u2003pg\/ml, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.005), IL\u20108 (107.5\u2003\u00b1\u200321.4\u2003pg\/ml, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) or TNF\u2010\u03b1 (22.5\u2003\u00b1\u20034.1\u2003pg\/ml, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) in 64 MCBD patients was significantly higher than that (2.1\u2003\u00b1\u20030.2, 5.7\u2003\u00b1\u20030.2 or 3.8\u2003\u00b1\u20030.2\u2003pg\/ml for IL\u20106, IL\u20108 or TNF\u2010\u03b1 level, respectively) in normal control subjects. In 43 MCBD patients with all the serum IL\u20106, IL\u20108 and TNF\u2010\u03b1 levels higher than their upper normal limits, treatment with levamisole plus colchicine for a period of 0.5\u201311.5 (mean, 3.2\u2003\u00b1\u20032.4) months could significantly reduce the mean serum IL\u20106, IL\u20108 and TNF\u2010\u03b1 levels from 9.0\u2003\u00b1\u20031.7 to 1.6\u2003\u00b1\u20030.2\u2003pg\/ml (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001), 134.6\u2003\u00b1\u200328.2\u20136.0\u2003\u00b1\u20030.4\u2003pg\/ml (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) and 25.7\u2003\u00b1\u20035.6\u20133.5\u2003\u00b1\u20030.4\u2003pg\/ml (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001), respectively.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Treatment with levamisole and colchicine can result in a significant reduction of serum IL\u20106, IL\u20108 or TNF\u2010\u03b1 level in MCBD patients.<\/jats:p>","DOI":"10.1111\/j.1600-0714.2009.00774.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T11:54:44Z","timestamp":1281614084000},"page":"401-405","source":"Crossref","is-referenced-by-count":26,"title":["Treatment with levamisole and colchicine can result in a significant reduction of IL\u20106, IL\u20108 or TNF\u2010\u03b1 level in patients with mucocutaneous type of Behcet\u2019s disease"],"prefix":"10.1111","volume":"38","author":[{"given":"Andy","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2010Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010San","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bu\u2010Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun\u2010Pin","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,13]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.suppl_2.ii51"},{"key":"e_1_2_5_3_2","first-page":"742","article-title":"Abnormalities of T lymphocytes subsets in Behcet\u2019s disease demonstrated with anti\u2010CD45RA and anti\u2010CD29 monoclonal antibodies","volume":"19","author":"Kahan A","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(96)00588-9"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/08916939209148460"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01684.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02688.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02695.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z"},{"key":"e_1_2_5_10_2","first-page":"2301","article-title":"Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behcet\u2019s disease","volume":"21","author":"Hamzaoui K","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(95)00439-4"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/030097402320318387"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/09629350220131935"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00907.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1076\/ocii.12.1.53.28062"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.47102\/annals-acadmedsg.V33N5p596","article-title":"Serum interleukin\u20102, interleukin\u20106, tumour necrosis factor\u2010alpha and nitric oxide levels in patients with Behcet\u2019s disease","volume":"33","author":"Akdeniz N","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(92)90207-6"},{"key":"e_1_2_5_18_2","first-page":"904","article-title":"Enhanced interleukin 8 secretion in circulation of patients with Behcet\u2019s disease","volume":"22","author":"Al\u2010Dalaan A","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_5_19_2","first-page":"249","article-title":"IL\u20108 producing cells in patients with Behcet\u2019s disease","volume":"18","author":"Mantas C","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000068888"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20334"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1994.tb01762.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050219"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030000128"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018426"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-003-0851-x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02184.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05497-6"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.22556"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.4.473"},{"key":"e_1_2_5_31_2","first-page":"321","article-title":"Cytokines in Behcet\u2019s disease","volume":"23","author":"Sayinalp N","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002960050091"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19801115)46:10<2185::AID-CNCR2820461015>3.0.CO;2-5"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(98)80028-0"},{"key":"e_1_2_5_35_2","first-page":"1544","article-title":"Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL)\u20106, IL\u20108 and increased neutrophil superoxide generation in Behcet\u2019s disease. A comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege JL","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2003.00096.x"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0904-2512.2004.00094.x"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00383.x"},{"key":"e_1_2_5_39_2","first-page":"4","volume-title":"Beh\u00e7et\u2019s syndrome: clinical and immunologic features","author":"Lehner T","year":"1979"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1994.tb01108.x"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2001.300906.x"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2002.310402.x"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06497.x"}],"container-title":["Journal of Oral Pathology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0714.2009.00774.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0714.2009.00774.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T06:54:19Z","timestamp":1697352859000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0714.2009.00774.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,13]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1600-0714.2009.00774.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0714.2009.00774.x","archive":["Portico"],"relation":{},"ISSN":["0904-2512","1600-0714"],"issn-type":[{"value":"0904-2512","type":"print"},{"value":"1600-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,13]]}}}